4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-18-054050
Chief Medical Officer sold 17,500 shares at $21.72 ($380,100)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2018-10-01 | Sale | −17,500 | $21.72 | $380,100 | 183,390 | I |
| Open-market sales · 17,500 sh · avg $21.72 · $380,100 | |||||||
Loading xslF345X03/doc4.xml…